Page 2 - Lance Willsey News Today

Exelixis, Inc. today announced that Lance Willsey, M.D. has informed the Board of Directors of his decision to resign from the Board, effective immediately. The Board recommends shareholders vote... | May 7, 2023

Files Definitive Proxy Materials and Sends Letter to Exelixis Shareholders Encourages Shareholders to Show that the Status Quo Cannot Continue by Voting to Elect All Three of Farallon’s... | May 3, 2023

Urges Shareholders to Vote FOR All of Exelixis’ 11 Recommended Director Nominees on the GOLD Proxy Card ... | May 1, 2023

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) (the “Company”) today announced that Carl Feldbaum, Esq. and Vincent Marchesi, M.D., Ph.D., two long-standing and valued members of the Board of Directors, will not stand for re-election at the Company’s 2023 Annual Meeting of Stockholders (the “Annual...

Pipo Derani continued an impressive streak of front row starting positions at the historic Sebring International Raceway on Friday. Derani earned the Motul Pole Award...

Blomqvist wins first GTP pole in a Roar Before the 24 session that lived up to the hype.

The first “official” marks of the IMSA WeatherTech SportsCar Championship’s 2023 season were set Sunday in Motul Pole Award qualifying to establish the lineup...

Arizona State Retirement System boosted its holdings in Exelixis, Inc. (NASDAQ:EXEL – Get Rating) by 0.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 85,527 shares of the biotechnology company’s stock after buying an additional 733 shares during the quarter. Arizona State Retirement […]

Integrated Advisors Network LLC lessened its holdings in Exelixis, Inc. (NASDAQ:EXEL – Get Rating) by 7.9% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 11,517 shares of the biotechnology company’s stock after selling 991 shares during the quarter. Integrated Advisors Network LLC’s holdings in […]

Comerica Bank grew its position in Exelixis, Inc. (NASDAQ:EXEL – Get Rating) by 1.1% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 143,777 shares of the biotechnology company’s stock after buying an additional 1,500 shares during the period. Comerica Bank’s holdings in Exelixis were […]